Can Fenbendazole Treat Cancer?

The Short Answer

Fenbendazole is a veterinary antiparasitic medicine. Researchers have found that it can affect cancer cells in laboratory experiments, and some animal studies have produced interesting results.

But there is a large difference between killing cancer cells in a laboratory and successfully treating cancer in a person.

There is currently no established clinical evidence showing that fenbendazole cures cancer, improves survival, or should be used as a cancer treatment in humans. It is not an approved human cancer treatment.

Can Fenbendazole Treat Cancer? What the Evidence Actually Shows

The scientific interest in fenbendazole is not completely invented. There is legitimate preclinical research behind some of the discussion.

A study published in Scientific Reports investigated fenbendazole in cancer cells and a mouse tumor model. Researchers reported that the drug interfered with microtubules—structures involved in cell division—and affected several biological pathways involved in cancer-cell survival.

The researchers also observed reduced tumor growth in their experimental mouse model.

These findings provide a reason to investigate the drug further. They do not demonstrate that fenbendazole is an effective cancer treatment in humans.

Why aren’t laboratory results enough?

Many substances can damage cancer cells in a laboratory. Only a fraction eventually become useful cancer treatments.

A potential treatment still has to answer much harder questions: Can enough of the drug reach a human tumor? What dose is safe? Does it work alongside other treatments? Which cancers might respond? And most importantly, does it actually help patients live longer or control their disease?

Those questions cannot be answered by cell experiments or animal models alone.

What Do We Know About Fenbendazole in People With Cancer?

This is where the evidence becomes much weaker.

Fenbendazole has not been established through high-quality human clinical trials as an effective cancer treatment. There is no reliable clinical evidence demonstrating that it improves tumor response, progression-free survival, or overall survival in cancer patients.

The American Cancer Society, in information developed with the American Society of Clinical Oncology (ASCO), has warned that claims surrounding fenbendazole go far beyond what current human evidence can support.

This distinction matters. A drug can have an interesting biological mechanism without being a proven treatment.

Why Did Fenbendazole Become So Popular Online?

Much of the public interest has come from personal cancer stories shared online.

Some people have reported taking fenbendazole while their cancer improved. These stories can sound compelling, particularly when someone has advanced cancer or has been told that treatment options are limited.

But anecdotes cannot determine what caused a patient’s improvement.

Cancer patients sharing these stories may also have received chemotherapy, immunotherapy, targeted therapy, radiation, surgery, or other treatments at the same time. Without a controlled clinical study, it is impossible to separate the possible effect of fenbendazole from the effects of established treatment, the natural course of the disease, or other factors.

A personal story can generate a research question. It cannot answer that question.

Could Fenbendazole Still Become a Cancer Drug?

Possibly—but that would have to be demonstrated through proper research.

Studying existing drugs for new purposes is known as drug repurposing. It is a legitimate area of cancer research, and some medicines originally developed for other conditions have eventually found roles in oncology.

Fenbendazole’s effects on microtubules and other cellular pathways make it scientifically interesting enough to investigate.

But “worth investigating” and “proven cancer treatment” are very different conclusions.

Could Taking Fenbendazole Be Harmful?

Yes. One problem is that fenbendazole products are manufactured for veterinary use rather than as approved medicines for human cancer treatment.

Human safety information is limited, and self-treatment means that dosing, interactions and monitoring may not be adequately understood.

There is also documented evidence of harm. A 2024 case report described severe drug-induced liver injury in a person who had been self-administering veterinary fenbendazole. The patient’s liver tests subsequently improved after fenbendazole was stopped.

A single case report cannot tell us how frequently this happens, but it demonstrates why describing an unapproved drug as harmless is not justified.

The most serious risk may occur when an experimental or unproven treatment delays, replaces, or interferes with cancer therapies that have demonstrated clinical benefit.

What We Still Don’t Know

Important questions remain unanswered.

Researchers would need well-designed human clinical trials to determine whether fenbendazole can achieve useful anticancer concentrations safely, which cancer types might respond, what dose and schedule would be appropriate, and whether it interacts with established cancer treatments.

Most importantly, trials would need to show whether fenbendazole improves meaningful outcomes for patients—not simply whether it affects cancer cells in a laboratory.

Sources

American Cancer Society / American Society of Clinical Oncology.
What to Know About Fenbendazole.
Clinical and patient guidance on the evidence surrounding fenbendazole and cancer.

Dogra N, Kumar A, Mukhopadhyay T.
Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways.
Scientific Reports. 2018.
DOI: 10.1038/s41598-018-30158-6

ACG Case Reports Journal.
Severe Drug-Induced Liver Injury Due to Self-administration of the Veterinary Anthelmintic Medication, Fenbendazole.
2024.
PMID: 38706451
DOI: 10.14309/crj.0000000000001354

Questions to Ask Your Doctor

• Is there any human clinical evidence for fenbendazole in my type of cancer?
• Could fenbendazole interact with my current cancer treatment or other medicines?
• Could taking it affect my liver or other organs?
• Are there legitimate clinical trials investigating drug repurposing for my cancer?

CancerSnoop explains cancer evidence for educational purposes. It does not diagnose cancer or recommend individual treatments. Decisions about cancer treatment should be made with your medical team.